PRESS RELEASE published on 10/02/2023 at 17:40, 2 years 5 months ago VALBIOTIS SA: the Phase II/III REVERSE-IT study selected for an oral presentation at the 2023 EASD congress, the main European learned society for diabetes
PRESS RELEASE published on 09/28/2023 at 17:40, 2 years 5 months ago Valbiotis publishes its financial report for the first half of 2023 and confirms its strategic roadmap
PRESS RELEASE published on 09/11/2023 at 17:40, 2 years 6 months ago VALBIOTIS SA: Valbiotis presents the full results of the Phase II/III REVERSE-IT study: impressive efficacy of TOTUM•63 against prediabetes and the early stages of type 2 diabetes
PRESS RELEASE published on 07/12/2023 at 17:40, 2 years 8 months ago Valbiotis announces its roadmap and strategic priorities on the eve of key milestones for its portfolio of innovative active substances
PRESS RELEASE published on 07/03/2023 at 17:40, 2 years 8 months ago Valbiotis announces the appointment of Charlotte JEZEQUEL as Director of Human Relations and Executive Committee member
Published on 03/23/2026 at 11:30, 37 minutes ago Trans Canada Gold Provides Update on Non-Brokered Private Placement and Flow-through Private Placement for Drilling at the Harrison Lake District Scale Gold Property Acquisition
Published on 03/23/2026 at 08:00, 4 hours 7 minutes ago ABRIDGED, PRELIMINARY AND UNAUDITED QUARTERLY AND FULL YEAR RESULTS AND DETAILS OF MANAGEMENT CONFERENCE Call for the Fourth Quarter and Full Year Ended December 31, 2025 ("The Quarter" or "Q4 2025" and "FY 2025" Respectively)
Published on 03/23/2026 at 02:00, 10 hours 7 minutes ago FutureGen Industries Announces Open Market Investments
Published on 03/23/2026 at 11:44, 22 minutes ago Viromed Medical AG receives funding approval from the Federal Ministry of Research, Technology and Space for the development of cold plasma technology
Published on 03/23/2026 at 11:05, 1 hour 2 minutes ago ASUS Unveils Complete Portfolio Support for Intel® Core™ 200S Series
Published on 03/23/2026 at 11:05, 1 hour 2 minutes ago BRAIN Biotech has been granted a key patent for its CRISPR-BMC genome-editing technology
Published on 03/23/2026 at 10:30, 1 hour 37 minutes ago TK Elevator appoints Brad Selleck as Chief Operating Officer; Vincent Della Valle to retire
Published on 03/20/2026 at 19:00, 2 days 17 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 18:15, 2 days 17 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 16:57, 2 days 19 hours ago Number of shares and voting rights - February 2026 (In French only)
Published on 03/19/2026 at 18:00, 3 days 18 hours ago Filing of the 2025 Universal Registration Document
